The relationship between the alveolar epithelial lining fluid concentration of intravenous plus inhaled polymyxin B and clinical efficacy in patients with pneumonia caused by carbapenem-resistant gram-negative bacilli: a prospective cohort study
This trial was registered. The Chinese trial registration number is ChiCTR2100044087. The date of registration is 9-3-2021. The registered name is that clinical study on intravenous drip and aerosol inhalation of polymyxin B for the treatment of pneumonia due to multidrug-resistant gram-negative bacteria.
Authors
- Qinyong Weng
- Wen‐Wei Wu (ORCID: https://orcid.org/0000-0002-8388-8417)
- Hongqiang Qiu (ORCID: https://orcid.org/0000-0003-3285-8768)
- Danjie Wang
- Lili Zhou (ORCID: https://orcid.org/0000-0001-5044-6965)
- Hui Zhang (ORCID: https://orcid.org/0000-0001-7770-2471)
- Xueyong Li (ORCID: https://orcid.org/0000-0002-4064-3735)
- Yu Cheng (ORCID: https://orcid.org/0000-0003-0610-1120)
- Xiuxia Huang
- Yiqin Lin
Institutions
- Fujian Medical University (CN)
- Union Hospital (US)
- Union Hospital (CN)
Publication Details
- Journal
- BMC Infectious Diseases
- Published
- 2025-09-26
- DOI
- https://doi.org/10.1186/s12879-025-11515-z
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.00